Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
HNRNPU - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RDH11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ARIH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VN1R1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPIEL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PSMA3-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SRPK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNAJC9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAS2R14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AP3M2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF165 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ODF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
S1PR5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBM8A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BMP8B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IMPAD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OGT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPL35A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on